|
Sign In to gain access to subscriptions and/or personal tools.
|
A nxiety and depression influence the relation between disability status and quality of life in multiple sclerosis
A CJW Janssens
Department of Neurology, Erasmus MC, PO Box 2040, 3000 CA, Rotterdam, the Netherlands, Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, the Netherlands
P A van Doorn
Department of Neurology, Erasmus MC, PO Box 2040, 3000 CA, Rotterdam, the Netherlands
J B de Boer
Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, the Netherlands
N F Kalkers
Department of Neurology, VU Medical Center, Amsterdam, the Netherlands
F GA van der Meché
Department of Neurology, Erasmus MC, PO Box 2040, 3000 CA, Rotterdam, the Netherlands
J Passchier
Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, the Netherlands
R Q Hintzen
Department of Neurology, Erasmus MC, PO Box 2040, 3000 CA, Rotterdam, the Netherlands, rhintzen{at}xs4all.nl
Disability status, depression and anxiety are important determinants of quality of life (Q oL) in patients with multiple sclerosis (MS). We investigated whether anxiety and depression influence the relation between disability status and Q oL in our cohort of recently diagnosed patients. Disability status [Expanded Disability Status Scale (EDSS)], anxiety and depression [Hospital A nxiety and Depression Scale (HADS)], and Q oL (SF-36) were prospectively obtained in 101 MS patients. The relation between EDSS and SF-36 scales was examined using regression analyses, without and with adjustment for anxiety and depression. Interaction effects were investigated by comparing the relation between EDSS and Q oL in patients with high and low anxiety and depression. In the unadjusted analyses, EDSS was significantly related to all SF-36 physical and mental health scales. A fter adjustment for anxiety and depression, EDSS was significantly related only to the SF-36 physical functioning, role-physical functioning and bodily pain scales. The relation between EDSS and these SF-36 scales was consistently higher in patients with more symptoms of anxiety or depression, suggesting that anxiety and depression strengthened the association of EDSS in these SF-36 physical health scales. A fter adjustment for anxiety and depression, EDSS was not significantly related to the SF-36 mental health scales and the general health scale. This finding is compatible with the hypothesis that anxiety and depression are intermediate factors in the association of EDSS with these SF-36 scales. Screening for symptoms of anxiety and depression is recommended in studies that use Q oL as an outcome measure of treatment or intervention efficacy.
Key Words: anxiety depression disability multiple sclerosis quality of life
Multiple Sclerosis, Vol. 9, No. 4,
397-403 (2003)
DOI: 10.1191/1352458503ms930oa

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S Kern, W Schrempf, H Schneider, T Schultheiss, H Reichmann, and T Ziemssen
Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis
Multiple Sclerosis,
June 1, 2009;
15(6):
752 - 758.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K Poder, K Ghatavi, J. Fisk, T. Campbell, S Kisely, I Sarty, K Stadnyk, and V Bhan
Social anxiety in a multiple sclerosis clinic population
Multiple Sclerosis,
March 1, 2009;
15(3):
393 - 398.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Simeoni, P. Auquier, O. Fernandez, P. Flachenecker, S. Stecchi, C. Constantinescu, E. Idiman, A. Boyko, A. Beiske, T. Vollmer, et al.
Validation of the Multiple Sclerosis International Quality of Life questionnaire
Multiple Sclerosis,
March 1, 2008;
14(2):
219 - 230.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vuger-Kovacic, R. Gregurek, D. Kovacic, T. Vuger, and B. Kalenic
Relation between anxiety, depression and locus of control of patients with multiple sclerosis
Multiple Sclerosis,
September 1, 2007;
13(8):
1065 - 1067.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S.R. Montel and C. Bungener
Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis
Multiple Sclerosis,
April 1, 2007;
13(3):
393 - 401.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M Korostil and A Feinstein
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Multiple Sclerosis,
January 1, 2007;
13(1):
67 - 72.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A C. Janssens, D Buljevac, P A van Doorn, F G. van der Meche, C H Polman, J Passchier, and R Q Hintzen
Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study
Multiple Sclerosis,
November 1, 2006;
12(6):
794 - 801.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F A H van der Linden, J J Kragt, J C Hobart, M Klein, A J Thompson, H M van der Ploeg, C H Polman, and B M J Uitdehaag
Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life
J. Neurol. Neurosurg. Psychiatry,
October 1, 2006;
77(10):
1157 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F A H van der Linden, J J Kragt, M Klein, H M van der Ploeg, C H Polman, and B M J Uitdehaag
Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use
J. Neurol. Neurosurg. Psychiatry,
December 1, 2005;
76(12):
1677 - 1681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A.J. Visschedijk, B. M.J. Uitdehaag, M. Klein, E. van der Ploeg, E. H. Collette, L. Vleugels, L. E.M.A. Pfennings, E. L.J. Hoogervorst, H. M. van der Ploeg, and C. H. Polman
Value of health-related quality of life to predict disability course in multiple sclerosis
Neurology,
December 14, 2004;
63(11):
2046 - 2050.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|